Bleeding edge Biotechnology

Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications

Kraig Biocraft's new silk-gland cell line is a reminder that biotech platforms do not always start with glamorous organisms. Sometimes the platform is a production cell that quietly changes what can be manufactured.

Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications
Visual brief for “Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications”.

What happened

The company says it has created immortalized silkworm silk gland cells with stable serial passaging, long-term viability, strong recombinant protein expression, and early adaptability to suspension culture. That matters because suspension culture is the bridge from clever biology to industrial bioprocessing.

The intriguing part is the expansion beyond spider-silk fibers. If silk gland biology can be used as a scalable expression system, the same genetic engineering stack could point toward therapeutic peptides, biologically active proteins, vaccines, and advanced biomaterials.

The frontier here is not just stronger silk. It is whether specialized animal cell biology can become a practical manufacturing substrate.

Source

Reported by Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications via globenewswire.com, published May 18, 2026.